Paradigm4 builds applications in collaboration with scientists and technologists at top R&D pharma companies in the world. Sometimes projects get waylaid due to internal reorganization within those companies, or market forces that are beyond the control of even those pharma giants. In those situations, some promising projects might not get sufficient exposure. Basically, Paradigm4 follows a sales driven development model, and as you can expect, such a model will have its pros (you do not develop something that the market does not want) and cons (like stated above).